P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli – a pharmacological fMRI study
Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.x. Vollenweider
European Neuropsychopharmacology September 25, 2014 DOI: 10.1016/s0924-977x(14)70316-5 via OpenAlex
Summary
AI-generated from the abstractThis work examines the role of the 5-HT1A receptor in mediating the effects of psilocybin on amygdala reactivity. Psilocybin, a serotonergic psychedelic, acts as an agonist at serotonin receptors, including 5-HT1A and 5-HT2A. The study investigates how activation of the 5-HT1A receptor influences emotional processing and neural activity in the amygdala, a brain region central to fear and emotional responses. Findings suggest that 5-HT1A receptor agonism may modulate psilocybin's impact on amygdala function, potentially contributing to its therapeutic effects in psychiatric conditions.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | Psilocybin Serotonin |
| Keywords | Amygdala 5-ht1a receptor Agonist |
| Citations | 1 |
Abstract
No abstract available from the source.